Publication of positive study results in a reputable journal like Lancet Respiratory Medicine often leads to increased investor confidence and can attract more attention to the company's stock. This could result in a short-term positive impact on GOSS's stock price, as it highlights the company's research capabilities and potential for future success in the respiratory medicine field.